Abstract

Psoriasis

Author(s): Fenrich Jon, Vidaurri Vincent

Issue: Sep/Oct 2000 - Compounding for Immune System Disorders

Page(s): 346

Download in electronic PDF format for $75
  • Psoriasis Page 1

Abstract

Psoriasis is a common skin disorder affecting around 2% of the US population. This article provides an overview of its causes, pathogenesis and therapeutic options. The authors end their discussion by suggesting that compounding pharmacists have more comprehensive tools to treat such diseases than those available to the average ambulatory pharmacist and that disseminating knowledge about the use of agents in the compounding armamentarium promotes the quality of life of the psoriatic patient.

Related Keywords

  • proliferation
  • cycloporine

Related Categories

  • DERMATOLOGY

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Sep/Oct 2000
Pg. 346
Psoriasis
Author(s): Fenrich Jon, Vidaurri Vincent
May/Jun 2017
Pg. 205-211
Management of Psoriasis with a XemaTop Topical Compounded Formula: A Case Report
Author(s): Jones Nat, Carvalho Maria, Branvold-Herr Andrea
Jan/Feb 2023
Pg. 57
Psoriasis Topical Ointment
Author(s): Allen Loyd V Jr
Jul/Aug 2022
Pg. 329
Psoriasis Topical Ointment
Author(s): Allen Loyd V Jr
Jul/Aug 2018
Pg. 270-278
Compounded Low-dose Naltrexone for the Treatment of Guttate Psoriasis: A Case Report
Author(s): Muller George, Grieshaber Robert, Talley J Floyd, Riepl Mike, Fellows Don
Mar/Apr 2020
Pg. 94-96
Low-dose Naltrexone Therapy for Psoriasis
Author(s): Weinstock Leonard B, Cottel Jill, Aldridge Lindsey, Egeberg Alexander
Jul/Aug 2020
Pg. 337-345
Evaluation of the Efficacy and Stability of Compounded Pentoxifylline-containing XemaTop for Psoriasis
Author(s): Song Guiyun, Ip Kendice, Shan Ashley, Banov Daniel, Bassani August S
Sep/Oct 2015
Pg. 357-365
Novel Approaches to Topical Psoriasis Therapy
Author(s): Koyama Gregory, Liu Jenny, Scaffidi Alyse, Khazraee Maryam, Epstein Benjamin
Jan/Feb 2016
Pg. 6-10
Extemporaneous Compounding of Oral Acitretin Suspension for Pediatric Patient with Generalized Pustular Psoriasis
Author(s): Choo Winnie
May/Jun 2011
Pg. 204-213
Treatment Options for Psoriasis
Author(s): Williams LaVonn A, Humphreys Erica
Jan/Feb 1999
Pg. 34-35
Case Reports: Steroid Substitute Treatment for Psoriasis; Metronidazole for Odor Related to Untreated Metastatic Breast Tumor
Author(s): Mason Dave
Jul/Aug 1998
Pg. 305
Psoriasis Ointment
Author(s): Allen Loyd V Jr
Sep/Oct 2000
Pg. 382
Psoriasis Nail Treatment
Author(s): Allen Loyd V Jr
Sep/Oct 2000
Pg. 383
Psoriasis Ointment, Heavy Moisturizing
Author(s): Allen Loyd V Jr
Sep/Oct 2011
Pg. 358-366
Infantile Hemangiomas, Part 1: Treatment with Oral Propranolol Hydrochloride
Author(s): Zur Eyal
Mar/Apr 2022
Pg. 94-98
A Compendium of Compounding Agents and Formulations, Part 2: Metronidazole, Misoprostol, and Phenytoin
Author(s): Riepl Mike
Mar/Apr 2023
Pg. 146
Cyclosporine Topical Microemulsion
Author(s): Allen Loyd V Jr
Jul/Aug 2021
Pg. 328
Tacrolimus 0.1% Topical Microemulsion
Author(s): Allen Loyd V Jr
Sep/Oct 2021
Pg. 419
Mycophenolate Mofetil 50-mg/mL in Ora-Plus:Cherry Syrup Suspension
Author(s): Allen Loyd V Jr
Nov/Dec 2011
Pg. 506
Thioguanine 20-mg/mL Oral Suspension
Author(s): Allen Loyd V Jr